Dr. Srinivas Iyengar, MD

Dr. Iyengar practices at UCSD Center for Surgery of Encinitas in Encinitas, California.

Dr. Iyengar's NPI, 1104030055, was assigned on May 10, 2007. Dr. Iyengar graduated from University of Colorado Anschutz Medical Campus in 2004. Dr. Iyengar holds California license A105824.

Dr. Iyengar's primary practice is UCSD Center for Surgery of Encinitas, at 477 N El Camino Real, Encinitas, CA 92024 in San Diego County. The practice phone is (661) 472-7434.

Dr. Iyengar's primary practice is UCSD Center for Surgery of Encinitas in Encinitas, California. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Iyengar to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iyengar practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Iyengar's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Iyengar is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Iyengar's licenses on file in 3 states: California, Kansas and Florida.

Dmand AI lists conjunctivitis, dry eye and eyelid inflammation among the conditions Dr. Iyengar treats.

CMS data shows 760 Medicare services from Dr. Iyengar across 14 procedure codes in 2024, for 367 Medicare patients. Medicare paid $68,726 for them.

CMS counts 367 Medicare patients who saw Dr. Iyengar in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high cholesterol, and 56% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Iyengar's median patient age at 71, with 61% women.

In 2024, Dr. Iyengar wrote 382 Medicare Part D claims for 210 patients. 87% of them were for generic drugs. CMS names the drug for 360 of them, across 3 drugs with 11 or more claims each, at $3,487 in total drug cost. In 2023, CMS named 397 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Iyengar for performance year 2024, reported individually. Dr. Iyengar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Iyengar in 2008. The most frequent topics are Eyelid Diseases. Dr. Iyengar has published most often in Ophthalmic Plast Reconstr Surg.

CMS Open Payments shows 57 general payments to Dr. Iyengar from 13 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 74% of the total. Horizon Pharma plc paid the most, $13,709.

Dmand AI lists 3 awards for Dr. Iyengar, most recently Top Doctors in 2019.

Dr. Iyengar graduated from University of Colorado Anschutz Medical Campus in 2004. Dr. Iyengar is a member of AAO and American Society of Ophthalmic Plastic and Reconstructive Surgery.

Dr. Iyengar is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.